Registry of Lobbyists
| Subject matters | Details | Categories |
|---|---|---|
|
Government Procurement, Health, Industry
|
Federal/Provincial/Territorial vaccine procurement programs administered by Public Services and Procurement Canada with regard to the recommendation and funding of vaccines through Public Health programs by governments in Canada, including issues that relate to the National Immunization Strategy.
|
Policies or Program
|
|
Health, Industry, Research and Development, Science and Technology
|
Seeking potential funding opportunities from the Strategic Innovation Fund to allow the company to further research, development and/or expansion of manufacturing.
|
Grant, Contribution or Other Financial Benefit
|
|
Education, Industry, Research and Development, Science and Technology
|
Support of the promotion of biotechnology and science education and innovation in Canada
|
Policies or Program
|
Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. We stand by the few who suffer from rare diseases and the millions with long-term chronic conditions. With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe. Vaccines at Sanofi provides more than 1 billion doses of vaccine each year, making it possible to immunize more than 500 million people across the globe. A world leader in the vaccine industry, Sanofi produces a portfolio of high quality vaccines that matches its areas of expertise and meets public-health demand. The company's heritage, to create vaccines that protect life, dates back more than a century.
Matthieu Puyet, Head of Manufacturing & Supply, Canada, Toronto Site Head
End date of the last completed financial year: 2023-12-31
| Government Institution | Funding Received in Last Financial Year | Funding Expected in Current Financial Year |
|---|---|---|
| Innovation, Science and Economic Development Canada (ISED) | $126,775,492.00 | Yes |
| Ontario Ministry of Economic Development, Job Creation and Trade | $7,000,000.00 | Yes |
| Ontario Ministry of Economic Development and Growth | $10,000,000.00 | Yes |
Address:
1755 Steeles Avenue West
Toronto, ON M2R 3T4
Canada
Telephone number:
416-399-8929
Sanofi Pasteur Limited does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
This is the responsible officer name as provided in the most recent registration for the corporation or organization.
| Name | From | To |
|---|---|---|
| Sanofi Pasteur Limited | 2024-05-09 | current |
| Sanofi Pasteur Limited | 2008-08-28 | 2024-05-09 |
| Responsible Officer Name | From (YYYY-MM-DD) | To (YYYY-MM-DD) |
|---|---|---|
| Matthieu Puyet | 2023-07-13 | Current |
| Fabien Marino | 2017-12-19 | 2023-07-13 |
| Lidia Serina | 2017-01-01 | 2017-12-19 |
| J .Mark Lievonen | 2005-08-16 | 2017-01-01 |
Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.
Note: Monthly Communication Reports are due on the 15th day of each month for communications that took place in the previous month.
Results below are sorted by posted date, beginning with the most recent.
Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.
Note: Monthly Communication Reports are due on the 15th day of each month for communications that took place in the previous month.
Results below are sorted by posted date, beginning with the most recent.